NCT03770858View on ClinicalTrials.gov

Wearable Skin Sensors to Assess Nocturnal Scratch Behavior

CompletedOBSERVATIONAL
Enrollment

23

Participants

Timeline

Start Date

April 18, 2019

Primary Completion Date

August 30, 2021

Study Completion Date

August 24, 2022

Conditions
Atopic Dermatitis
Interventions
DRUG

Crisaborole

Subject to apply topical crisaborole twice daily to the affected atopic dermatitis areas

DEVICE

Scratch sensor

advanced, flexible and wearable skin sensor

Trial Locations (1)

60611

Northwestern University, Chicago

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Northwestern University

OTHER